Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
235.99
-3.90 (-1.63%)
At close: Jan 16, 2026, 4:00 PM EST
236.20
+0.21 (0.09%)
After-hours: Jan 16, 2026, 7:38 PM EST
Danaher Market Cap
Danaher has a market cap or net worth of $166.69 billion as of January 16, 2026. Its market cap has increased by 0.54% in one year.
Market Cap
166.69B
Enterprise Value
183.32B
1-Year Change
0.54%
Ranking
Category
Stock Price
$235.99
Market Cap Chart
Since December 1, 1998, Danaher's market cap has increased from $6.13B to $166.69B, an increase of 2,621.32%. That is a compound annual growth rate of 12.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 166.69B | 3.09% |
| Dec 31, 2025 | 161.70B | -2.47% |
| Dec 31, 2024 | 165.80B | -3.01% |
| Dec 29, 2023 | 170.94B | -11.53% |
| Dec 30, 2022 | 193.22B | -17.82% |
| Dec 31, 2021 | 235.10B | 48.98% |
| Dec 31, 2020 | 157.80B | 43.14% |
| Dec 31, 2019 | 110.24B | 52.53% |
| Dec 31, 2018 | 72.28B | 11.94% |
| Dec 29, 2017 | 64.57B | 19.92% |
| Dec 30, 2016 | 53.84B | -15.41% |
| Dec 31, 2015 | 63.65B | 5.68% |
| Dec 31, 2014 | 60.23B | 11.90% |
| Dec 31, 2013 | 53.82B | 39.00% |
| Dec 31, 2012 | 38.72B | 19.93% |
| Dec 30, 2011 | 32.29B | 4.66% |
| Dec 31, 2010 | 30.85B | 27.69% |
| Dec 31, 2009 | 24.16B | 33.51% |
| Dec 31, 2008 | 18.09B | -33.56% |
| Dec 31, 2007 | 27.23B | 22.14% |
| Dec 29, 2006 | 22.30B | 29.74% |
| Dec 30, 2005 | 17.19B | -3.00% |
| Dec 31, 2004 | 17.72B | 25.76% |
| Dec 31, 2003 | 14.09B | 40.70% |
| Dec 31, 2002 | 10.01B | 16.16% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |